Blood donor eligibility would be based on individual assessment under new guidelines
The Food and Drug Administration released a set of proposed guidelines that would determine blood donor eligibility based on individual assessment.
In late January, the FDA put out a set of proposed changes to current rules and guidelines that would allow previously deferred individuals from donating blood.
"If we can increase the amount of people that are eligible, then we're looking to increase that 3 percent to something higher and help our local hospitals and patients and blood supply," Kari Lundeen with Nebraska Community Blood Bank said.
Previously, the FDA had in place a policy that issued a lifetime deferral on blood donations for gay and bisexual men in order to reduce the chance of HIV in the blood supply. That was revised in 2015 when the FDA made it a 12-month deferral for men who have sex with men. The policy was again changed in 2020 to the current 3-month deferral.
In a statement sent to KETV the American Red Cross said, in part: "The Red Cross is pleased the FDA has proposed to determine blood donor eligibility using gender-inclusive, individual risk-based assessment regardless of sexual orientation...There is more work to be done, and we will continue to provide date to the FDA in support of further progress.
The draft would eliminate time-based deferrals for men who have sex with men, the current donor history questionnaire would be revised, and a prospective donor who doesn't report having new or multiple sexual partners may be eligible to donate - among other details.
The process involves a public comment period [which the FDA is currently in], final guidance, revised donor questionnaires and an update on operational procedures, information systems and staff training.
To give comments of any kind please follow this link.
To read the release from the FDA click here.